Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 9;11(3):705-724.
doi: 10.14336/AD.2019.0718. eCollection 2020 May.

The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer's Disease-related Pathogenesis

Seong Gak Jeon  1 , Anji Yoo  1 , Dong Wook Chun  1 , Sang Bum Hong  1 , Hyunju Chung  2 , Jin-Il Kim  3 , Minho Moon  1
Affiliations
Review

The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer's Disease-related Pathogenesis

Seong Gak Jeon et al. Aging Dis. .

Abstract

Several studies have revealed that the transcription factor nuclear receptor related 1 (Nurr1) plays several roles not only in the regulation of gene expression related to dopamine synthesis, but also in alternative splicing, and miRNA targeting. Moreover, it regulates cognitive functions and protects against inflammation-induced neuronal death. In particular, the role of Nurr1 in the pathogenesis of Parkinson's disease (PD) has been well investigated; for example, it has been shown that it restores behavioral and histological impairments in PD models. Although many studies have evaluated the connection between Nurr1 and PD pathogenesis, the role of Nurr1 in Alzheimer's disease (AD) remain to be studied. There have been several studies describing Nurr1 protein expression in the AD brain. However, only a few studies have examined the role of Nurr1 in the context of AD. Therefore, in this review, we highlight the overall effects of Nurr1 under the neuropathologic conditions related to AD. Furthermore, we suggest the possibility of using Nurr1 as a therapeutic target for AD or other neurodegenerative disorders.

Keywords: Alzheimer’s disease; NR4A2; Nurr1; memory; neuroinflammation; neuroprotection.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors have no conflict of interest to declare.

Figures

Figure 1.
Figure 1.
Overview of effect of Nurr1 in Alzheimer’s disease.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Germain P, Staels B, Dacquet C, Spedding M, Laudet V (2006). Overview of nomenclature of nuclear receptors. Pharmacol Rev, 58:685-704. - PubMed
    1. Wang Z, Benoit G, Liu J, Prasad S, Aarnisalo P, Liu X, et al. (2003). Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature, 423:555-560. - PubMed
    1. Zetterstrom RH, Williams R, Perlmann T, Olson L (1996). Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res, 41:111-120. - PubMed
    1. Saucedo-Cardenas O, Conneely OM (1996). Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system. J Mol Neurosci, 7:51-63. - PubMed
    1. Luo Y (2012). The function and mechanisms of Nurr1 action in midbrain dopaminergic neurons, from development and maintenance to survival. Int Rev Neurobiol, 102:1-22. - PubMed

LinkOut - more resources